Some patients with ankylosing spondylitis (AS) or nonradiographic axial spondyloarthritis (SpA) do not receive adequate relief from nonsteroidal anti-inflammatory drugs (NSAIDs). In these cases, the updated guideline for treating patients with these diseases addresses several possible medication regimens for continued therapy. Which of the following treatment recommendations are strongly recommended in the guideline?
Better luck next time
Nice job!
Rheumatology and Arthritis Learning Network® is an online resource for the latest developments in rheumatology practice, providing a customized experience for readers to stay informed about the topics that matter most to them.
Upadacitinib Shows Positive Results in Clinical Trials for AS, nr-axSpA
Late-Breaking Results from Phase 3 Trials of Risankizumab